Javier Casado Varela

Javier Casado Varela

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
CFCláudia Fernandes
Cláudia Fernandes
VVVanessa Viegas
Vanessa Viegas
MCManuel Saavedra Centeno
Manuel Saavedra Centeno
JVJavier Casado Varela
Javier Casado Varela
ASAna Sánchez
Ana Sánchez
LLLuis López- Fando Lavalle
Luis López- Fando Lavalle

18 June 2025 in Continence
Verified
Journal Article
Open access
CFCláudia Fernandes
Cláudia Fernandes
VVV. Viegas
V. Viegas
AMAlberto Artiles Medina
Alberto Artiles Medina
JHJ. Morale Herrea
J. Morale Herrea
JVJavier Casado Varela
Javier Casado Varela
LLLuis López- Fando Lavalle
Luis López- Fando Lavalle

4 October 2022
Verified
Conference Paper
Closed access
ARAna Sánchez Ramírez
Ana Sánchez Ramírez
LSLuis San-José
Luis San-José
LWLeopoldo Cogorno Wasylkowski
Leopoldo Cogorno Wasylkowski
FRFrancisco Javier Gonzálvez Rodriguez
Francisco Javier Gonzálvez Rodriguez
GLGuillermo Celada Luis
Guillermo Celada Luis
CBClara Velasco Balanza
Clara Velasco Balanza
Introduction: Nontraumatic splenic rupture is a rare event. Bladder cancer usually metastasizes to the lymph nodes, bone, lung, liver and periton |

9 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RPRui Pedrosa
Rui Pedrosa
CMCarlos Marquez
Carlos Marquez
MCManuel Saavedra Centeno
Manuel Saavedra Centeno
CBClara Velasco Balanza
Clara Velasco Balanza
LMLira Pelari Mici
Lira Pelari Mici
LLLuis López- Fando Lavalle
Luis López- Fando Lavalle
Background/Objectives: Mesh-related complications after surgery for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) remain a clinical challenge, and surgical revision is often required. However, its impact on functional outcomes and continence status is incompletely defined. This study aimed to evaluate voiding and continence outcomes after surgical revision of vaginal synthetic mesh. Methods: This retrospective multicenter study included 55 consecutive women undergoing surgical revision of synthetic mesh for symptomatic complications after SUI or POP procedures between March 2021 and April 2025. Preoperative evaluation included clinical assessment, uroflowmetry, and selective imaging or urodynamic studies. Surgical management included mesh section, partial removal, or total removal via vaginal, abdominal, or combined approaches. The primary outcome was change in Qmax and post-void residual (PVR). Secondary outcomes included symptom resolution, changes in urgency urinary incontinence (UUI) and SUI, and postoperative complications. Results: Obstructive voiding dysfunction was the leading indication for revision (47.3%). Median Qmax increased from 13.0 to 18.0 mL/s (p = 0.0013), and median PVR decreased from 55.0 to 5.0 mL (p < 0.001). UUI improved from 56.4% to 34.5% (p = 0.017, McNemar’s exact test). Conversely, SUI increased from 20.0% to 56.4% (p < 0.001), although only 16 patients (29.1%) had clinically significant postoperative SUI, of whom 7 underwent a secondary anti-incontinence procedure. Intraoperative complications were infrequent (5.5%), while postoperative urinary tract infections occurred in 16.4%. Conclusions: Mesh revision surgery improves voiding function and reduces storage symptoms in selected patients but carries a substantial risk of recurrent or de novo SUI, underscoring the need for careful patient selection and counseling, with an acceptable safety profile in experienced centers.